Singapore markets closed

Straits Times Index
3,348.87
+12.28(+0.37%)
S&P 500
5,272.02
-5.49(-0.10%)
Dow
38,456.86
-229.46(-0.59%)
Nasdaq
16,798.31
+63.30(+0.38%)
Bitcoin USD
69,101.73
+1,071.16(+1.57%)
CMC Crypto 200
1,487.94
+20.01(+1.36%)

BMY Jun 2024 38.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

4.5100

+1.5100

(+50.33%)

As of 10:39AM EDT. Market open.

Business Wire
Bristol Myers Squibb’s Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
PRINCETON, N.J., June 03, 2024--BMS' Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
Business Wire
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer
PRINCETON, N.J., June 03, 2024--Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations...
Business Wire
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer
PRINCETON, N.J., June 01, 2024--KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced....